Geode Capital Management, LLC Onconova Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.57 - $1.0 $17,799 - $31,228	31,228 Added 16.19%	224,086 $132,000
Q3 2023 Nov 13, 2023	BUY	$0.71 - $1.15 $16,583 - $26,860	23,357 Added 13.78%	192,858 $136,000
Q4 2022 Feb 13, 2023	SELL	$0.63 - $0.97 $217 - $335	-346 Reduced 0.2%	169,501 $109,000
Q2 2022 Aug 12, 2022	BUY	$1.04 - $1.9 $7,153 - $13,068	6,878 Added 4.22%	169,847 $224,000
Q4 2021 Feb 11, 2022	SELL	$2.49 - $3.73 $36,007 - $53,939	-14,461 Reduced 8.15%	162,969 $415,000
Q3 2021 Nov 12, 2021	BUY	$3.81 - $6.76 $131,254 - $232,882	34,450 Added 24.09%	177,430 $679,000
Q2 2021 Aug 13, 2021	BUY	$6.28 - $16.2 $897,914 - $2.32 Million	142,980 New	142,980 $990,000

2.85M

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.